Literature DB >> 16926591

Blood group A and B antigen expression in human kidneys correlated to A1/A2/B, Lewis, and secretor status.

Michael E Breimer1, Johan Mölne, Gunnela Nordén, Lennart Rydberg, Gilbert Thiel, Christian T Svalander.   

Abstract

BACKGROUND: In the revived interest in crossing ABO barriers in organ transplantation renal A/B antigen expression has been correlated with donor ABO, Lewis, and secretor subtype to predict antigen expression.
METHODS: A/B antigen expression was explored by immunohistochemistry in LD renal biopsies. Donor A1/A2/B, Lewis, and secretor status were determined by serology and polymerase chain reaction.
RESULTS: In the renal vascular bed, three distinct A antigen expression patterns with a major, minor, and minimal staining distribution, and intensity (designated as types 3+, 1+ and (+) respectively) were identified. Type 3+ had a strong A antigen expression in the endothelium of arteries, glomerular/peritubular capillaries and veins. The type 1+ showed an overall weaker antigen expression, whereas type (+) had faint staining of peritubular capillaries only. In all cases, distal tubular epithelium was focally stained, whereas proximal tubules were negative. Type 3+ were all from blood group A1 subtype individuals while A2 cases expressed either a 1+ or (+) pattern. The secretor gene did not appear to influence renal A antigen expression. All B kidneys examined showed a B antigen pattern slightly weaker but otherwise similar to A type 3+.
CONCLUSION: Renal vascular A antigen expression correlates to donor A1/A2 subtypes, whereas B individuals show one singular antigen pattern. From antigen perspective, A1 and B donors are a "major" and A2 individuals a "minor" antigen challenge in ABO-incompatible renal transplantation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16926591     DOI: 10.1097/01.tp.0000231697.15817.51

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  26 in total

Review 1.  Immunogenicity and allogenicity: a challenge of stem cell therapy.

Authors:  Dominique Charron; Caroline Suberbielle-Boissel; Reem Al-Daccak
Journal:  J Cardiovasc Transl Res       Date:  2008-09-26       Impact factor: 4.132

2.  ABO-incompatible kidney transplantation.

Authors:  Friedrich Thaiss
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

3.  Vienna experience of ABO-incompatible living-donor kidney transplantation.

Authors:  Michael Haidinger; Sabine Schmaldienst; Günther Körmöczi; Heinz Regele; Afschin Soleiman; Dieter Schwartz; Kurt Derfler; Rudolf Steininger; Ferdinand Mühlbacher; Georg A Böhmig
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

Review 4.  Immunohaematological and apheretic aspects of the first kidney transplant from a living, ABO-incompatible donor carried out in Italy.

Authors:  Maria Sassi; Umberto Maggiore; Carlo Buzio; Massimo Franchini
Journal:  Blood Transfus       Date:  2010-11-26       Impact factor: 3.443

5.  Blood Group A antigen expression on cardiac endothelium is highly individualized: possible implications for transplantation.

Authors:  Eric A Gehrie; Justin M Cates; Hui Nian; Sandy J Olson; Pampee P Young
Journal:  Cardiovasc Pathol       Date:  2013-01-04       Impact factor: 2.185

6.  ABO blood group polymorphism has an impact on prostate, kidney and bladder cancer in association with longevity.

Authors:  Donatas Stakišaitis; Milda Juknevičienė; Albertas Ulys; Dalia Žaliūnienė; Daiva Stanislovaitienė; Ramunė Šepetienė; Anželika Slavinska; Kęstutis Sužiedėlis; Vita Lesauskaitė
Journal:  Oncol Lett       Date:  2018-05-21       Impact factor: 2.967

7.  Prognostic value of ABO blood group in patients with renal cell carcinoma: single-institution results from a large cohort.

Authors:  Chunwoo Lee; Dalsan You; Mooyoung Sohn; In Gab Jeong; Cheryn Song; Taekmin Kwon; Bumsik Hong; Jun Hyuk Hong; Hanjong Ahn; Choung-Soo Kim
Journal:  J Cancer Res Clin Oncol       Date:  2015-02-17       Impact factor: 4.553

8.  Underutilization of A2 ABO incompatible kidney transplantation.

Authors:  Robert R Redfield; Ronald F Parsons; Eduardo Rodriguez; Moiz Mustafa; James Cassuto; Kumar Vivek; Hooman Noorchashm; Ali Naji; Matthew H Levine; Peter L Abt
Journal:  Clin Transplant       Date:  2011-10-27       Impact factor: 2.863

9.  Outcomes of ABO-incompatible kidney transplantation in the United States.

Authors:  John R Montgomery; Jonathan C Berger; Daniel S Warren; Nathan T James; Robert A Montgomery; Dorry L Segev
Journal:  Transplantation       Date:  2012-03-27       Impact factor: 4.939

Review 10.  Strategies to overcome the ABO barrier in kidney transplantation.

Authors:  Georg A Böhmig; Andreas M Farkas; Farsad Eskandary; Thomas Wekerle
Journal:  Nat Rev Nephrol       Date:  2015-09-01       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.